PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $909,000 | -40.7% | 1,463,810 | -7.4% | 0.00% | 0.0% |
Q1 2019 | $1,533,000 | +25.0% | 1,580,610 | +1.6% | 0.00% | 0.0% |
Q4 2018 | $1,226,000 | -29.1% | 1,555,410 | +16.9% | 0.00% | -50.0% |
Q3 2018 | $1,730,000 | -49.0% | 1,331,100 | -49.1% | 0.00% | 0.0% |
Q2 2018 | $3,394,000 | +82.6% | 2,615,400 | +92.7% | 0.00% | 0.0% |
Q1 2018 | $1,859,000 | -9.0% | 1,356,900 | -8.3% | 0.00% | 0.0% |
Q4 2017 | $2,043,000 | -14.1% | 1,480,300 | -6.0% | 0.00% | -33.3% |
Q3 2017 | $2,379,000 | +19.1% | 1,575,500 | +0.9% | 0.00% | 0.0% |
Q2 2017 | $1,998,000 | +4.6% | 1,561,300 | +0.5% | 0.00% | 0.0% |
Q1 2017 | $1,911,000 | -6.2% | 1,553,800 | +9.1% | 0.00% | 0.0% |
Q4 2016 | $2,037,000 | -2.9% | 1,424,800 | +8.6% | 0.00% | -25.0% |
Q3 2016 | $2,098,000 | +37.1% | 1,311,500 | +14.0% | 0.00% | +33.3% |
Q2 2016 | $1,530,000 | -5.6% | 1,150,400 | +14.3% | 0.00% | 0.0% |
Q1 2016 | $1,621,000 | +20.9% | 1,006,800 | -15.2% | 0.00% | 0.0% |
Q4 2015 | $1,341,000 | +91.8% | 1,187,048 | +209.3% | 0.00% | +50.0% |
Q3 2015 | $699,000 | -9.8% | 383,800 | +24.7% | 0.00% | 0.0% |
Q2 2015 | $775,000 | +2.6% | 307,700 | +14.0% | 0.00% | 0.0% |
Q1 2015 | $755,000 | +41.4% | 269,800 | +26.2% | 0.00% | +100.0% |
Q4 2014 | $534,000 | +214.1% | 213,713 | +259.8% | 0.00% | – |
Q3 2014 | $170,000 | +49.1% | 59,394 | +62.7% | 0.00% | – |
Q2 2014 | $114,000 | – | 36,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|